12-44665604-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000429094.7(NELL2):c.1324G>A(p.Asp442Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,611,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D442Y) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000429094.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NELL2 | NM_001145108.2 | c.1324G>A | p.Asp442Asn | missense_variant | 13/20 | ENST00000429094.7 | NP_001138580.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NELL2 | ENST00000429094.7 | c.1324G>A | p.Asp442Asn | missense_variant | 13/20 | 1 | NM_001145108.2 | ENSP00000390680 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000681 AC: 17AN: 249760Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135028
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1459516Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726096
GnomAD4 genome AF: 0.000184 AC: 28AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.1474G>A (p.D492N) alteration is located in exon 14 (coding exon 14) of the NELL2 gene. This alteration results from a G to A substitution at nucleotide position 1474, causing the aspartic acid (D) at amino acid position 492 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at